文献速递主动脉疾病

急性主动脉综合征患者血清促红细胞生成素水平的预后价值:真实世界分析

Prognostic Value of Serum Erythropoietin Levels in Acute Aortic Syndrome: A Real-World Analysis.
PubMed 文献 · Ann Vasc Surg · 2026-07-16

本研究对254例急性主动脉综合征患者进行真实世界分析,中位随访18.1个月,73例死亡。Cox回归显示log EPO(HR 2.491,P<0.001)、Stanford A型(HR 3.003,P<0.001)和手术/TEVAR治疗(HR 0.283,P<0.001)是全因死亡的独立预测因素。EPO≤16 IU/mL患者生存率和无事件率显著更高,血清EPO水平与不良结局密切相关,具有良好预后价值。

要点

  • log EPO是AAS全因死亡的独立预测因素(HR 2.491,P<0.001)。
  • EPO≤16 IU/mL患者生存率和无事件率显著更高。
  • EPO与炎症指标正相关,与白蛋白负相关。

核心结论

  • 血清EPO水平与急性主动脉综合征不良结局密切相关,具有良好预后价值。

研究设计与样本

  • 真实世界分析,纳入254例急性主动脉综合征患者,中位随访18.1个月。

主要发现

  • 73例死亡;Cox回归显示log EPO(HR 2.491,P<0.001)、Stanford A型(HR 3.003,P<0.001)和手术/TEVAR(HR 0.283,P<0.001)是全因死亡的独立预测因素。
  • Kaplan-Meier曲线显示EPO≤16 IU/mL患者生存率和无事件率显著更高。
  • 列线图显示log EPO对AAS预后贡献最大;亚组分析中log EPO是A型AAS和未手术/TEVAR患者的重要预后指标。
  • EPO与C反应蛋白、IL-4、IL-6和单核细胞正相关,与白蛋白负相关;升主动脉最大直径与EPO在AAS和主动脉夹层患者中正相关;假腔直径和面积与EPO在主动脉夹层患者中正相关。

临床怎么用

  • 血清EPO水平可作为急性主动脉综合征预后评估的参考指标,尤其对A型及未手术/TEVAR患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: It is currently unclear whether erythropoietin (EPO) has value in predicting the prognosis of acute aortic syndrome (AAS). METHODS: A real-world analysis was conducted on the relationship between EPO and AAS outcomes. The primary end points were all-cause mortality and aortic-related mortality. The major adverse cardiac and cerebral events included all-cause mortality, acute myocardial infarction, stroke, and secondary procedures. Serum EPO concentration was examined using the Quantikine Human EPO ELISA. RESULTS: A total of 254 AAS patients were recruited, of whom 73 died. The median time of follow-up was 18.1 months. In Cox regression analysis, log EPO (hazard ratio [HR]: 2.491, P < 0.001), Stanford type A (HR: 3.003, P < 0.001), and treatment with surgery/thoracic endovascular aortic repair (TEVAR; HR: 0.283, P < 0.001) were independent predictors of all-cause mortality. In Kaplan-Meier curves, patients with EPO ≤16 IU/mL had significantly higher survival and event-free rates. Nomograms indicated that log EPO had the greatest contribution to AAS prognosis. In subgroup analysis, log EPO was an important prognostic indicator for patients with type A AAS and those treated without surgery/TEVAR. In correlation analyses, EPO was positively correlated with C-reactive protein, interleukin (IL)-4, IL-6, and monocytes and negatively correlated with albumin. The maximum diameter of the ascending aorta was positively correlated with EPO in AAS and aortic dissection (AoD) patients. The false lumen diameter and false lumen area were positively correlated with EPO in AoD patients. CONCLUSION: The serum EPO level is closely associated with the adverse outcomes of AAS and has good prognostic value.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Gao Z, Li G, Yin C, et al. Prognostic Value of Serum Erythropoietin Levels in Acute Aortic Syndrome: A Real-World Analysis. Ann Vasc Surg. 2026. PMID: 42462904. doi:10.1016/j.avsg.2026.07.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。